BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22069609)

  • 1. Ochratoxins-food contaminants: impact on human health.
    Reddy L; Bhoola K
    Toxins (Basel); 2010 Apr; 2(4):771-9. PubMed ID: 22069609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ochratoxin a: general overview and actual molecular status.
    el Khoury A; Atoui A
    Toxins (Basel); 2010 Apr; 2(4):461-93. PubMed ID: 22069596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats.
    Mally A; Hard GC; Dekant W
    Food Chem Toxicol; 2007 Nov; 45(11):2254-60. PubMed ID: 17629386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary cholestyramine reduces ochratoxin A-induced nephrotoxicity in the rat by decreasing plasma levels and enhancing fecal excretion of the toxin.
    Kerkadi A; Barriault C; Tuchweber B; Frohlich AA; Marquardt RR; Bouchard G; Yousef IM
    J Toxicol Environ Health A; 1998 Feb; 53(3):231-50. PubMed ID: 9482354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ochratoxin A in Slaughtered Pigs and Pork Products.
    Vlachou M; Pexara A; Solomakos N; Govaris A
    Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicokinetics and toxicodynamics of ochratoxin A, an update.
    Ringot D; Chango A; Schneider YJ; Larondelle Y
    Chem Biol Interact; 2006 Jan; 159(1):18-46. PubMed ID: 16293235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of mycotoxins in the development of endemic nephropathy.
    Peraica M; Domijan AM; Miletić-Medved M; Fuchs R
    Wien Klin Wochenschr; 2008; 120(13-14):402-7. PubMed ID: 18726664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How aspartame prevents the toxicity of ochratoxin A.
    Creppy EE; Baudrimont I; Anne-Marie
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():165-72. PubMed ID: 9760456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ochratoxin A: previous risk assessments and issues arising.
    Walker R; Larsen JC
    Food Addit Contam; 2005; 22 Suppl 1():6-9. PubMed ID: 16332615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic pathways of ochratoxin A.
    Wu Q; Dohnal V; Huang L; Kuča K; Wang X; Chen G; Yuan Z
    Curr Drug Metab; 2011 Jan; 12(1):1-10. PubMed ID: 21222585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ochratoxin A, ubiquitous mycotoxin contaminating human food].
    Pfohl-Leszkowicz A
    C R Seances Soc Biol Fil; 1994; 188(4):335-53. PubMed ID: 7736257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of ochratoxin: current views of the European Scientific Committee on Food, the JECFA and the Codex Committee on Food Additives and Contaminants.
    Walker R
    Adv Exp Med Biol; 2002; 504():249-55. PubMed ID: 11922092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries.
    Malir F; Ostry V; Pfohl-Leszkowicz A; Roubal T
    Biomarkers; 2012 Nov; 17(7):577-89. PubMed ID: 22642623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.
    Faucet-Marquis V; Pont F; Størmer FC; Rizk T; Castegnaro M; Pfohl-Leszkowicz A
    Mol Nutr Food Res; 2006 May; 50(6):530-42. PubMed ID: 16671059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ochratoxin A in human blood in Abidjan, Côte d'Ivoire.
    Sangare-Tigori B; Moukha S; Kouadio JH; Dano DS; Betbeder AM; Achour A; Creppy EE
    Toxicon; 2006 Jun; 47(8):894-900. PubMed ID: 16626769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of nephrotoxicity of ochratoxin A, a food contaminant.
    Creppy EE; Baudrimont I; Betbeder AM
    Toxicol Lett; 1995 Dec; 82-83():869-77. PubMed ID: 8597155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Ochratoxin Toxicity: A Review of the Available Data.
    Heussner AH; Bingle LE
    Toxins (Basel); 2015 Oct; 7(10):4253-82. PubMed ID: 26506387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxic effects of Ochratoxin A in Wistar rats after oral administration.
    Alvarez L; Gil AG; Ezpeleta O; García-Jalón JA; López de Cerain A
    Food Chem Toxicol; 2004 May; 42(5):825-34. PubMed ID: 15046829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of DNA adducts in tissues of mouse progeny through transplacental contamination and/or lactation after administration of a single dose of ochratoxin A to the pregnant mother.
    Petkova-Bocharova T; Stoichev II; Chernozemsky IN; Castegnaro M; Pfohl-Leszkowicz A
    Environ Mol Mutagen; 1998; 32(2):155-62. PubMed ID: 9776178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ochratoxin A in human kidney diseases.
    Fuchs R; Peraica M
    Food Addit Contam; 2005; 22 Suppl 1():53-7. PubMed ID: 16332622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.